Tag: 2026
FSSAI Suspends License of Dior Pharmaceuticals Over Critical Violations at Nutraceutical Manufacturing Unit
The Food Safety and Standards Authority of India (FSSAI) has officially suspended the manufacturing license of Dior Pharmaceuticals with immediate effect, following a comprehensive...
JP Nadda Urges Bengal MPs to Join the Fight Against TB
Union Health Minister J.P. Naddamet with West Bengal's Members of Parliament in New Delhi on Wednesday, urging cross-party lawmakers to spearhead grassroots efforts against tuberculosis...
AstraZeneca reports Mixed Phase III Results for Ultomiris in Rare Post-Transplant Blood Disorder
AstraZeneca's Alexion unit has reported divergent outcomes from its late-stage program testing Ultomiris (ravulizumab) in patients with thrombotic microangiopathy following hematopoietic stem cell transplant (HSCT-TMA), a rare and...
Government of Andhra Pradesh Partners to Launch AI and Genomic-Powered 360-Degree Oncology Care Model
The Government of Andhra Pradesh has announced a strategic partnership to implement a groundbreaking 360-degree oncology care model designed to transform early cancer detection,...
From Research to Revolution: Novo Nordisk Shares Oral GLP-1 Breakthrough Story
Novo Nordisk has shared the scientific journey behind turning an injectable biologic medicine into a pill — a challenge researchers have wrestled with since...
Biozenta Lifescience to Build ₹1,250 Crore Oncology Plant in Barabanki, UP
Biozenta Lifescience Pvt. Ltd., a global leader in oncology medicines, has announced plans to establish a state-of-the-art manufacturing facility in Barabanki, Uttar Pradesh, marking a major milestone for...
